Our Pricing

Lansoprazole vs Omeprazole UK Comparison

When considering a lansoprazole vs omeprazole UK comparison, both medications are proton pump inhibitors (PPIs) licensed to treat acid reflux, gastro-oesophageal reflux disease (GORD), and peptic ulcers. At Cured Pharmacy, you'll find transparent pricing on both treatments from £9.99, with free clinical assessment by UK prescribers to determine which option suits your symptoms best.

How Lansoprazole and Omeprazole Work

Both lansoprazole and omeprazole belong to the proton pump inhibitor (PPI) class, working by blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells [1]. This mechanism reduces stomach acid production by up to 90%, providing sustained relief from acid-related symptoms throughout the day.

The key difference lies in their chemical structure: omeprazole is a racemic mixture of two mirror-image molecules (enantiomers), whilst esomeprazole—a related PPI—contains only the S-enantiomer [1]. Lansoprazole has a slightly different benzimidazole structure, which may influence how quickly it's activated in acidic environments [2].

In clinical practice, both medications typically achieve symptom relief within 2-3 days, with maximum acid suppression occurring after 4-5 days of consistent use [2]. Your UK prescriber will assess your symptoms, medical history, and any concurrent medications to recommend the most appropriate PPI for your needs.

Lansoprazole vs Omeprazole: Efficacy and Clinical Evidence

Multiple head-to-head trials have compared lansoprazole and omeprazole for treating gastro-oesophageal reflux disease and peptic ulcers. A systematic review of randomised controlled trials found no significant difference in healing rates for erosive oesophagitis between lansoprazole 30mg and omeprazole 20mg after 8 weeks of treatment [3].

For Helicobacter pylori eradication—a common cause of peptic ulcers—both PPIs demonstrate comparable efficacy when combined with appropriate antibiotics. Studies show eradication rates of 80-85% with either lansoprazole or omeprazole as part of triple therapy regimens [3][4].

In terms of symptom control, both medications provide effective relief from heartburn, regurgitation, and epigastric pain. Some patients report faster symptom improvement with lansoprazole, though this varies individually and hasn't been consistently demonstrated across all trials [2][3].

Dosing Considerations

Standard dosing differs slightly between the two medications. Omeprazole is typically prescribed at 20mg once daily for acid reflux, whilst lansoprazole is usually given as 30mg once daily [1][2]. Both are taken in the morning, 30 minutes before food, to maximise acid suppression during daytime meals. Your prescriber may adjust doses based on symptom severity and response to treatment.

Side Effects: Lansoprazole vs Omeprazole

The side effect profiles of lansoprazole and omeprazole are remarkably similar, as expected from medications in the same therapeutic class. Common side effects include headache (affecting approximately 2-5% of patients), nausea, diarrhoea, constipation, and abdominal pain [1][4].

Long-term PPI use—with either medication—has been associated with slightly increased risks of vitamin B12 deficiency, hypomagnesaemia (low magnesium), and potential bone fracture risk, particularly in elderly patients or those taking high doses for extended periods [4]. The MHRA advises that patients on long-term PPIs should have their treatment reviewed regularly by a healthcare professional.

Rare but serious side effects include severe allergic reactions, liver function abnormalities, and subacute cutaneous lupus erythematosus. If you experience unexplained weight loss, difficulty swallowing, persistent vomiting, or black tarry stools whilst taking either medication, contact your GP immediately as these may indicate more serious underlying conditions requiring investigation.

Drug Interactions and Contraindications

Both lansoprazole and omeprazole are metabolised primarily by the liver enzyme CYP2C19, which means they can interact with medications processed by the same pathway [1]. Omeprazole has more documented interactions with drugs like clopidogrel (a blood thinner), warfarin, and certain antifungals.

Lansoprazole may be preferred in patients taking clopidogrel, as it shows less interference with the antiplatelet effects compared to omeprazole [4]. However, your prescriber will review all your current medications during the clinical assessment to identify potential interactions.

Both PPIs can reduce the absorption of medications requiring stomach acid for proper dissolution, including certain antifungals (ketoconazole, itraconazole) and HIV medications. They may also affect the absorption of vitamin B12 and iron over prolonged use [4].

When to Avoid PPIs

Neither lansoprazole nor omeprazole should be used if you're allergic to any PPI medication. They should be used cautiously in patients with severe liver disease, and dosage adjustments may be necessary. Pregnant or breastfeeding women should discuss PPI use with their healthcare provider, though omeprazole has more established safety data in pregnancy and is generally preferred when a PPI is necessary [1].

Cost Comparison: Lansoprazole vs Omeprazole at Cured Pharmacy

At Cured Pharmacy, omeprazole capsules start from £9.99, making it one of the most cost-effective PPI options available in the UK. Lansoprazole capsules are available from £9.99, representing excellent value compared to typical high street pricing.

Both medications require a free online consultation with a UK-registered prescriber before dispensing. The consultation takes under 3 minutes to complete and ensures the treatment is clinically appropriate for your symptoms and medical history. There are no hidden fees—the price you see includes prescribing, dispensing, and discreet delivery to your door.

For patients who have previously used PPIs and know which medication works best for them, our streamlined assessment process makes reordering straightforward. If you're new to PPI treatment, our prescribers can recommend the most suitable option based on your symptoms, concurrent medications, and clinical factors.

Which PPI Should You Choose?

For most patients, both lansoprazole and omeprazole provide equally effective acid suppression and symptom relief. The choice often comes down to individual response, cost considerations, and specific drug interactions. If you're taking clopidogrel or have experienced side effects with one PPI, switching to the alternative may be beneficial [3][4].

Some patients find one medication works better for their symptoms than the other, despite similar clinical trial outcomes. This individual variation is common with PPIs and may relate to genetic differences in CYP2C19 enzyme activity, which affects how quickly these medications are metabolised [1].

Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), and the UK-registered clinical team at Cured Pharmacy can guide you through the selection process during your free consultation. We consider your symptom severity, previous treatment response, concurrent medications, and cost preferences to recommend the most appropriate PPI for your needs. All treatments are genuine UK-licensed medicines dispensed from our GPhC-registered pharmacy (9012511).

When to Seek Further Medical Advice

Whilst PPIs effectively manage acid reflux symptoms in most patients, certain warning signs require urgent GP review. Contact your doctor immediately if you experience difficulty swallowing, unintentional weight loss, persistent vomiting, vomiting blood, or black tarry stools. These symptoms may indicate complications requiring endoscopic investigation or alternative treatment approaches beyond PPI therapy.

Scientific References

1. Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current Gastroenterology Reports, 10(6), 528–534. https://doi.org/10.1007/s11894-008-0098-4
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 85(6), 582–588. https://doi.org/10.1038/clpt.2009.23
3. Edwards, S. J., et al. (2001). Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis—a comparison of esomeprazole with other PPIs. Alimentary Pharmacology & Therapeutics, 15(11), 1729–1736. https://doi.org/10.1046/j.1365-2036.2001.01111.x
4. Medicines and Healthcare products Regulatory Agency. (2012). Proton pump inhibitors: very low risk of subacute cutaneous lupus erythematosus. Drug Safety Update, 5(10), A1. https://www.gov.uk/drug-safety-update

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.